By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



Meibergdreef 61

  Amsterdam  1105 BA  Netherlands
Phone: 31-20-566-7394 Fax: 31-20-566-9272



Company News
uniQure (QURE) Announces Presentations At Upcoming February Conferences 2/6/2017 8:00:11 AM
uniQure (QURE) Announces FDA Breakthrough Therapy Designation For AMT-060 In Hemophilia B 1/30/2017 9:17:21 AM
uniQure (QURE) Release: Company Appoints Alexander Kuta As Senior Vice President Of Regulatory Affairs 1/25/2017 11:30:15 AM
uniQure (QURE) Appoints Matthew Kapusta As Chief Executive Officer 12/19/2016 8:30:15 AM
uniQure (QURE) Announces First Clinical Data From Second Dose Cohort Of AMT-060 In Ongoing Phase I/II Trial In Patients With Severe Hemophilia B 12/5/2016 9:56:46 AM
uniQure (QURE) To Present At The Genetic Rx Boston Biotech Conference At Harvard Medical School 12/2/2016 9:49:59 AM
uniQure (QURE) Announces Financial Results For Third Quarter 2016 And Provides Update On Company Progress 11/22/2016 8:24:29 AM
uniQure (QURE) Shakes Up R&D to Refocus Pipeline, to Eliminate 20-25% of Workforce By End of 2017 11/15/2016 6:45:37 AM
uniQure (QURE) Announces Upcoming Presentation Of Data At Annual American Society of Hematology Meeting 11/3/2016 9:07:33 AM
uniQure (QURE) To Present At The Jefferies Gene Editing And Gene Therapy Summit In New York City 9/26/2016 8:30:31 AM